GGrantIndex
Sort

65,743 grants matching single cell sequencing

Predictive Modeling of the Functional and Phenotypic Impacts of Genetic Variants

$752,388
Zhiping Weng · Univ Of Massachusetts Med Sch Worcester · U01 · FY2022 · HG

Leveraging the Rich Genetic Diversity of Vagal Motor Neurons to Decode Brain-to-Gut Communication

$752,385
Bradford B Lowell · Beth Israel Deaconess Medical Center · R01 · FY2019 · DK

Spatiotemporal analysis of gene regulatory programs associated with GBS infection during pregnancy

$752,360
Itai Yanai · New York University School Of Medicine · R01 · FY2022 · AI

Human cardiac microtissues with innate immune sensing to study adverse consequences of genome editing

$752,330
John Travis Hinson · University Of Connecticut Sch Of Med/Dnt · U01 · FY2019 · EB

Oxidative Stress and Regional Airway Remodeling and Fibrosis in Obese Asthma

$752,281
Loretta G Que · Duke University · R01 · FY2020 · HL

T cells in the aging brain

$752,242
Anne Brunet · Stanford University · R01 · FY2021 · AG

3/3 Genomics of Schizophrenia in the South African Xhosa

$752,229
Dan Joseph Stein · University Of Cape Town · U01 · FY2023 · MH

Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses

$752,147
Kamal Mohan Khanna · New York University School Of Medicine · R01 · FY2025 · DK

Mechanisms of Immune Activation in Hypertension

$752,131
David G Harrison · Vanderbilt University Medical Center · R35 · FY2019 · HL

Mechanisms of Immune Activation in Hypertension

$752,131
David G Harrison · Vanderbilt University Medical Center · R35 · FY2020 · HL

The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)

$752,119
Nicholas T. Funderburg · Ohio State University · U01 · FY2024 · AI

Collaborative Research: RESEARCH-PGR: Comparative genomics of the capitulum: deciphering the molecular basis of a key floral innovation

$752,045
Daniel S Jones · Auburn University · · FY2022 · BIO

In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas

$752,016
Michael A Dyer · St. Jude Children'S Research Hospital · U01 · FY2022 · CA

Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma

$752,010
Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Cancer Genomics Technology Development

$751,988
Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Generating Exogenic Organs for Transplantation without the Use of Immunosuppression

$751,986
Clifford J. Steer · University Of Minnesota · R01 · FY2022 · AI

High-throughput Deep Sequencing Assay to Reliably Measure the HIV Reservoir during Antiretroviral Therapy

$751,984
David Mitchell Smith · University Of California, San Diego · R01 · FY2018 · AI

Inhalable stem cell exosome therapy for cardiac injury

$751,983
Ke Cheng · Columbia Univ New York Morningside · R01 · FY2024 · HL

Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping

$751,954
Han Zhu · Stanford University · R01 · FY2024 · HL

Molecular mechanisms of structural plasticity of inhibitory GABAergic interneurons

$751,941
Anton Maximov · Scripps Research Institute, The · R01 · FY2020 · MH

The Role Of Innate Immunity Genes In Viral Infection and Disease Progression

$751,925
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Initiation Of DNA Replication In Mammalian Chromosomes

$751,906
Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD

Mechanisms of Immune Activation in Hypertension

$751,897
David G Harrison · Vanderbilt University Medical Center · R35 · FY2021 · HL

Molecular Analysis of Developmental Brain Disorders Associated with Synaptic Pathology

$751,798
Scott H Soderling · Duke University · R01 · FY2023 · MH

Regulators of immune complex mediated neutrophil antigen presentation

$751,797
Tanya N. Mayadas · Brigham And Women'S Hospital · R01 · FY2023 · HL